Verition Fund Management
CBST

Verition Fund Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Verition Fund Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,000
Closed -$209K – 992
2014
Q2 		$209K Buy
+3,000
New +$204K 0.02% 540

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Verition Fund Management's CBST Position: Q3 2014 in Review

Verition Fund Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 13,356 shares — an estimated $933K sold.

Verition Fund Management first reported a position in CBST in Q2 2013 and held it in 2 quarters. The position peaked at $933K in Q2 2014. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • Verition Fund Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Verition Fund Management sold 13,356 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $933K.
  • Verition Fund Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Verition Fund Management's CUBIST PHARMACEUTICALS INC position peaked at $933K in Q2 2014.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on Verition Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.